Detalhe da pesquisa
1.
Metastases-directed stereotactic body radiotherapy in combination with targeted therapy or immunotherapy: systematic review and consensus recommendations by the EORTC-ESTRO OligoCare consortium.
Lancet Oncol
; 24(3): e121-e132, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36858728
2.
High-dose radiotherapy and risk-adapted androgen deprivation in localised prostate cancer (DART 01/05): 10-year results of a phase 3 randomised, controlled trial.
Lancet Oncol
; 23(5): 671-681, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35427469
3.
Androgen deprivation therapy use and duration with definitive radiotherapy for localised prostate cancer: an individual patient data meta-analysis.
Lancet Oncol
; 23(2): 304-316, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35051385
4.
Health-related quality of life in men with localized prostate cancer treated with radiotherapy: validation of an abbreviated version of the Expanded Prostate Cancer Index Composite for Clinical Practice in Spain.
Health Qual Life Outcomes
; 19(1): 223, 2021 Sep 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-34563208
5.
Corrigendum to "Uroncor consensus statement: Management of biochemical recurrence after radical radiotherapy for prostate cancer: From biochemical failure to castration resistance". [Rep. Pract. Oncol. Radiother. 20 (2015) 259-272].
Rep Pract Oncol Radiother
; 21(1): 90-2, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26900365
6.
High-dose radiotherapy with short-term or long-term androgen deprivation in localised prostate cancer (DART01/05 GICOR): a randomised, controlled, phase 3 trial.
Lancet Oncol
; 16(3): 320-7, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25702876
7.
Three linked nomograms for predicting biochemical failure in prostate cancer treated with radiotherapy plus androgen deprivation therapy.
Strahlenther Onkol
; 191(10): 792-800, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26156249
8.
Uroncor consensus statement: Management of biochemical recurrence after radical radiotherapy for prostate cancer: From biochemical failure to castration resistance.
Rep Pract Oncol Radiother
; 20(4): 259-72, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26109913
9.
Functional imaging guided stereotactic ablative body radiotherapy (SABR) with focal dose escalation and bladder trigone sparing for intermediate and high-risk prostate cancer: study protocol for phase II safo trial.
Radiat Oncol
; 19(1): 54, 2024 May 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38702761
10.
Prognostic Impact of Prostate-Specific Antigen at 6 Months After Radiotherapy in Localized Prostate Cancer: An Individual Patient Data Analysis of Randomized Trials.
J Clin Oncol
; : JCO2300762, 2024 Mar 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38471051
11.
Node Oligorecurrence in Prostate Cancer: A Challenge.
Cancers (Basel)
; 15(16)2023 Aug 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-37627187
12.
ESTRO ACROP guideline on prostate bed delineation for postoperative radiotherapy in prostate cancer.
Clin Transl Radiat Oncol
; 41: 100638, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37251620
13.
ESTRO ACROP consensus recommendation on the target volume definition for radiation therapy of macroscopic prostate cancer recurrences after radical prostatectomy.
Clin Transl Radiat Oncol
; 43: 100684, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37808453
14.
PEACE V-Salvage Treatment of OligoRecurrent nodal prostate cancer Metastases (STORM): Acute Toxicity of a Randomized Phase 2 Trial.
Eur Urol Oncol
; 2023 Oct 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37821242
15.
Sequencing of Androgen-Deprivation Therapy of Short Duration With Radiotherapy for Nonmetastatic Prostate Cancer (SANDSTORM): A Pooled Analysis of 12 Randomized Trials.
J Clin Oncol
; 41(4): 881-892, 2023 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36269935
16.
Biochemical Recurrence Surrogacy for Clinical Outcomes After Radiotherapy for Adenocarcinoma of the Prostate.
J Clin Oncol
; 41(32): 5005-5014, 2023 Nov 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37639648
17.
Sensitivity of a helical diode array device to delivery errors in IMRT treatment and establishment of tolerance level for pretreatment QA.
J Appl Clin Med Phys
; 13(1): 3660, 2012 Jan 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-22231218
18.
[Molecular markers as predictive factors biochemical failure after radical treatment of prostate cancer]. / Marcadores moleculares como factores predictivos de fracaso bioquímico en el cáncer de próstata después de tratamiento radical.
Arch Esp Urol
; 65(1): 61-78, 2012.
Artigo
em Espanhol
| MEDLINE | ID: mdl-22318178
19.
Advances in Transversal Topics Applicable to the Care of Bladder Cancer Patients in the Real-World Setting.
Cancers (Basel)
; 14(16)2022 Aug 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36010964
20.
MRI-guided focal boost to dominant intraprostatic lesion using volumetric modulated arc therapy in prostate cancer. Results of a phase II trial.
Br J Radiol
; 95(1131): 20210683, 2022 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34538073